Inovio Pharmaceuticals Inc (NASDAQ:INO) price on current trading day, fall -6.67% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $1.96.
A look at the stock’s price movement, the close in the last trading session was $2.10, moving within a range at $1.92 and $2.125. Turning to its 52-week performance, $14.75 and $1.74 were the 52-week high and 52-week low respectively. Overall, INO moved -10.50% over the past month.
Inovio Pharmaceuticals Inc’s market cap currently stands at around $70.76 million, with investors looking forward to this quarter’s earnings report slated for on 2025-Mar-17.
Wall Street analysts have also projected the company’s year-on-year revenue to grow to 40k, representing a -81.63% decline on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that INO is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
3 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 1 analyst(s) rate the stock as a Hold, 2 recommend INO as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
INO’s current price about -2.27% and -4.12% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 45.43, while 7-day volatility ratio is 7.61% and 7.23% in the 30-day chart. Further, Inovio Pharmaceuticals Inc (INO) has a beta value of 1.72, and an average true range (ATR) of 0.14. Analysts have given the company’s stock an average 52-week price target of $20, forecast between a low of $8 and high of $40. Looking at the price targets, the low is -308.16% off current price level while to achieve the yearly target high, price needs to move -1940.82%. Nonetheless, investors will most likely welcome a -920.41% jump to $20 which is the analysts’ median price.
If we refocus on Inovio Pharmaceuticals Inc (NASDAQ:INO), historical trading data shows that trading volumes averaged 0.56 over the past 10 days and 857.13K over the past 3 months. The company’s latest data on shares outstanding shows there are 36.10 million shares.
The 0.69% of Inovio Pharmaceuticals Inc’s shares are in the hands of company insiders while institutional holders own 37.08% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 5.52 million on 2025-02-28, giving us a short ratio of 7.86. The data shows that as of 2025-02-28 short interest in Inovio Pharmaceuticals Inc (INO) stood at 1538.0 of shares outstanding, with shares short rising to 5.01 million registered in 2025-01-31. Current price change has pushed the stock 7.10% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the INO stock continues to rise going into the next quarter.
